Investor says troubled biotech company still has potential


    Local businessman Martin Svendson, a shareholder in the much-hyped, early-stage biotech TransGenRx for about eight years, is part of a group that's trying "to bring the company back to life." The comp…

    Already an INSIDER? .

    We are glad you enjoy reading Business Report.

    Continue reading this story and get ACCESS to all our content from any device with a subscription now.

    • Get access to more than a decade of story archives.
    • Get access to our searchable data center of TOP LISTS.
    • Get exclusive content only available to INSIDERS.